With promising pre-clinical data and several companies poised to gain IND approval in the next year, the in vivo cell and gene industry is at the threshold of transformation. Lucrative partnerships and investments are driving this evolution, presenting an ideal moment for you to seize our tailored sponsorship packages, empowering your company to build meaningful relationships with key thought-leaders and support them in driving the evolution of this field.  

The 3rd In Vivo Cell Engineering & Gene Editing Summit is an exclusive meeting dedicated to uniting key opinion leaders and decision-makers in biopharma, all seeking strategic partners to support their shared ambition of pioneering the next frontier of cell and gene therapies.

Our bespoke partnership packages offer a unique opportunity for your company to elevate its influence and ensure its position as a trusted innovator in this space.